Side B — Companies (Angel → Series B)
Aureum Aletheia provides companies with a neutral, institutional-grade diagnostic of their capital readiness. Not a pitch coach. Not advisory. A structured mirror that shows you exactly what institutional capital will see — before they see it.
The Value of Neutral Assessment
When you commission an independent structural analysis of your company, you are demonstrating that your leadership values evidence over narrative. Institutional capital recognizes this signal.
A neutral deal memo from an independent platform carries a different weight than a founder-authored pitch deck. It signals that you have subjected your own company to the same scrutiny that capital will apply — and that you are prepared for what they will find.
The outputs are yours to use: share them with investors to accelerate diligence, use them internally as a governance audit instrument, or use them to identify and address structural gaps before your next capital conversation.
Simulate how institutional capital will evaluate your company. Identify structural weaknesses before they become deal-killers. Arrive at every capital conversation with verified clarity about your own position.
A neutral, structured deal memo generated by an independent platform carries institutional credibility. Share it with investors as evidence of governance maturity and operational transparency.
Use the diagnostic outputs as an internal governance audit. Identify gaps in board structure, reporting standards, and compliance architecture before they surface in external diligence.
Commissioning independent structural analysis signals institutional seriousness. It demonstrates that your leadership prioritizes evidence over narrative.
What to Expect
01
All outputs are written in the register of institutional capital evaluation. No startup hype. No motivational language. Structured intelligence only.
02
Outputs distinguish facts from assumptions. Uncertainty is flagged explicitly. Claims are verified against available evidence. Nothing is fabricated.
03
Every scoring decision shows its reasoning. Every classification is traceable. You will understand exactly why each output was generated.
04
Structural vulnerabilities are identified clearly and without softening. Risk clarity over optimism. This is what capital will see.
05
All outputs are delivered to your private portal. Share them with investors, use them for internal governance review, or retain them as audit documentation.
06
Aureum Aletheia does not provide investment advice, legal advice, or valuation opinions. We provide structured intelligence. Decisions remain yours.
Service Menu
$19.99 one-time Platform Access Fee. Services commissioned per report. Three tiers aligned to company stage.
Tier 1 — Angel & Seed
AI-powered institutional deal memo covering all seven scoring categories. Structured output with composite score, letter grade, and traffic light rating.
Full seven-category scoring with weighted composite formula. Numeric score (0–10), letter grade (A+ → D/F), and traffic light classification.
Automated identification of all categories scoring below 5 (red flags) and above 7 (key strengths). Remediation guidance included.
Tier 2 — Series A & B
Full automated deal memo, composite score, and gaps & strengths analysis as included in the Angel & Seed tier.
Extended financial model review, unit economics deep-dive, and capital efficiency assessment relative to stage and sector benchmarks.
Expanded competitive analysis with comparable company mapping (public and private) and defensibility assessment.
Tier 3 — Enterprise & Custom
Bespoke evaluation framework tailored to specific transaction type, sector, and institutional requirements.
Human DD expert review layered on top of the automated analysis. Direct access to senior analysts throughout the process.
Integration with internal diligence systems, data rooms, and workflow tools for enterprise capital operations.
Investor Pipeline Access
Companies that achieve a Green rating (A or A+) are invited to have their standardized deal memo confidentially shared with our curated network of active capital providers. This is not a pitch platform. It is a structured introduction channel for verified, high-readiness companies.
The memo shared is the same neutral, structured document generated by the platform. No additional materials required. No pitch coaching. The quality of your readiness speaks through the structure of the output.
Pipeline Eligibility
Account & Pricing
A one-time $19.99 Platform Access Fee activates your Company portal. Services are then commissioned on demand and priced per report. No subscription. No auto-renewal. No lock-in.
Tier 1
$500
Angel & Seed · 24hr
Tier 2
$1,500
Series A & B · 48hr
Tier 3
Custom
Enterprise · Custom
Frequently Asked
Who sees my diagnostic results?
Only you. Diagnostic outputs are private to your account. They are never shared with capital providers or any third party without your explicit action.
Can I share my deal memo with investors?
Yes. All outputs include a shareable link that you control. You decide what to share, with whom, and when.
Is this a pitch coaching service?
No. Aureum Aletheia is a neutral diagnostic platform. We do not coach, advocate, or optimize your narrative. We provide structured intelligence about your current state.
What if the results are unfavorable?
That is the point. Identifying structural weaknesses before capital encounters them gives you the opportunity to address them. Unfavorable results are actionable intelligence.
How is pricing structured?
A one-time $19.99 Platform Access Fee activates your Company portal. Reports are then commissioned per engagement: Tier 1 (Angel & Seed) is $500 with 24-hour delivery; Tier 2 (Series A & B) is $1,500 with 48-hour delivery; Tier 3 (Enterprise) is custom-scoped and priced.